logo

For the Inventor, By the Inventor

Travedona Monate, Italy

Helena Posteri

USPTO Granted Patents = 11 

 

 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 15(Granted Patents)


Location History:

  • Varese, IT (2013)
  • Travedona Monate, IT (2012 - 2015)

Company Filing History:

goldMedal11 out of 138 
 
Nerviano Medical Sciences S.r.l.
 patents

Years Active: 2012-2015

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 9073893 - [object Object] (2015-07-07),
2. 8993594 - Isoquinolin-1(2H)-one derivatives as PARP-1 inhibitors (2015-03-31),
3. 8846701 - Pyrazolo-quinazolines (2014-09-30),
4. 8765972 - [object Object] (2014-07-01),
5. 8623876 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2014-01-07),
6. 8614220 - Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors (2013-12-24),
7. 8598172 - Substituted dihydropteridin-6-one derivatives, process for their preparation and their use as kinase inhibitors (2013-12-03),
8. 8592416 - Isoquinolin-1 (2H)-one derivatives as PARP-1 inhibitors (2013-11-26),
9. 8426417 - Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors (2013-04-23),
10. 8309578 - Bicyclic pyrazole and isoxazole derivatives as antitumor and antineurodegenerative agents (2012-11-13),
11. 8227472 - Substituted pyrrolo-pyrazole derivatives as kinase inhibitors (2012-07-24),

Title: Helena Posteri: Innovator in Pharmaceutical Chemistry

Introduction

Helena Posteri is a prominent inventor based in Travedona Monate, Italy. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target poly (ADP-ribose) polymerases. With a total of 11 patents to her name, her work has the potential to impact the treatment of various diseases.

Latest Patents

Among her latest patents, Helena has developed 3-oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives. These compounds selectively inhibit the activity of poly (ADP-ribose) polymerase PARP-1 in comparison to PARP-2. This innovation is particularly useful in treating diseases such as cancer, cardiovascular diseases, central nervous system injuries, and various forms of inflammation. Additionally, she has created substituted isoquinolin-1(2H)-one derivatives that also serve as PARP-1 inhibitors, providing similar therapeutic benefits. Her patents include methods for preparing these compounds, pharmaceutical compositions containing them, and treatment methods utilizing these compositions.

Career Highlights

Helena has worked with notable companies in the pharmaceutical industry, including Nerviano Medical Sciences and Les Laboratoires Servier. Her experience in these organizations has allowed her to refine her expertise and contribute to groundbreaking research in drug development.

Collaborations

Helena has collaborated with esteemed colleagues such as Maria Gabriella Brasca and Michele Caruso. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Helena Posteri is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new treatments for serious health conditions. Her innovative patents and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…